slide1 l.
Download
Skip this Video
Loading SlideShow in 5 Seconds..
Ensuring Proper Use and Curbing Abuse of Opioids: An Industry Perspective PowerPoint Presentation
Download Presentation
Ensuring Proper Use and Curbing Abuse of Opioids: An Industry Perspective

Loading in 2 Seconds...

play fullscreen
1 / 28

Ensuring Proper Use and Curbing Abuse of Opioids: An Industry Perspective - PowerPoint PPT Presentation


  • 179 Views
  • Updated on

Ensuring Proper Use and Curbing Abuse of Opioids: An Industry Perspective. J. David Haddox, DDS, MD Senior Medical Director, Health Policy Purdue Pharma L.P. FDA ALSDAC January 31, 2002. Outline. Disease Burden of Chronic Pain Treatment of Chronic Pain

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

Ensuring Proper Use and Curbing Abuse of Opioids: An Industry Perspective


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
    Presentation Transcript
    1. Ensuring Proper Use and Curbing Abuse of Opioids: An Industry Perspective J. David Haddox, DDS, MD Senior Medical Director, Health Policy Purdue Pharma L.P. FDA ALSDAC January 31, 2002

    2. Outline • Disease Burden of Chronic Pain • Treatment of Chronic Pain • Prescription Drug Abuse and Diversion • Risk Management Plans

    3. Disease Burden from Chronic Pain • No overall national statistics • Surveys (representative demographics) • State of Pain Survey (EPIC/MRA 1997) • Chronic Pain in America (RSW 1999) • Patients’ Attitudes Towards Opioids (HI 2002)

    4. “State of Pain” – 1997Michigan Pain Study – a statewide survey • 1.2 out of 9.8 million population have chronic pain • 77% experienced pain for over a year • 35% missed 20+ days of work in past year • 13% denied medications, devices or referral to pain specialists • 10% have thought about committing suicide

    5. Chronic Pain in America – 1999Roadblocks to Relief • Focused on moderate to severe, chronic pain, not due to cancer • 9% of all US adults suffer this type of pain • Verbal Pain Estimate Ranges (0-10 Scale): • 5-6 (43%) 7 (23%) 8-10 (34%)

    6. Chronic Pain in America – 1999Roadblocks to Relief • 51% seeing primary care physician • 2/3 have lived with pain for 5+ years • 78% reported daily pain • 10% admit to turning to alcohol for pain relief

    7. Attitudes and Beliefs 2002 N = 1439 Patients with chronic pain, taking an opioid at least 4 months Most commonly reported: arthritis, low back pain, migraine, cancer Analgesics: C-II 638; CIII-V 1125; NSAIDs 1398; APAP 820 VPE Ranges (1-10): 1-3 11%; 4-7 67%; 8-10 22% Pain Controlled? Well 18%, Sometimes 62%, Not 20% Well Controlled: 39% 3+ MDs and 38% took 6 months + to get control Not Controlled: 65% 3+ MDs and 92% have been trying 9+ months

    8. Attitudes and Beliefs 2002 “Patients do not have trouble obtaining needed pain medicines.” 54% Disagree “I have not experienced any problems getting treatment for my pain.” 35% Disagree

    9. Attitudes and Beliefs 2002 Imagine that a patient was taking a pain medication for 6 months and suddenly stopped taking it. As a result of not taking the medication they experienced nausea, sweats, had difficulty sleeping, and felt tense and jittery. Based on this information, can you state conclusively that the patient is..? • Addicted to the medication • Physically dependent on the medication • Both addicted and physically dependent on the medication • Neither addicted nor physically dependent on the medication • Not sure

    10. Attitudes and Beliefs 2002 Imagine that a patient was taking a pain medication for 6 months and suddenly stopped taking it. As a result of not taking the medication they experienced nausea, sweats, had difficulty sleeping, and felt tense and jittery. Based on this information, can you state conclusively that the patient is..? • Addicted to the medication • Physically dependent on the medication • Both addicted and physically dependent on the medication • Neither addicted nor physically dependent on the medication • Not sure 16% 37% 35% 2% 10%

    11. Addiction Addiction is a primary, chronic, neurobiologic disease, with genetic, psychosocial, and environmental factors influencing its development and manifestations. It is characterized by behaviors that include one or more of the following: impaired control over drug use, compulsive use, continued use despite harm, and craving. AAPM, ASAM, APS -- 2001

    12. Physical Dependence Physical dependence is a state of adaptation that is manifested by a drug class specific withdrawal syndrome that can be produced by abrupt cessation, rapid dose reduction, decreasing blood level of the drug, and / or administration of an antagonist. AAPM, ASAM, APS -- 2001

    13. Physical Therapy Therapy for Comorbidities Pharmacotherapy Rehabilitation Services Cognitive Therapies Surgery Behavioral Therapies Nerve Blocks, etc Integrated Treatment Approach for Chronic Pain Individualized Care Plan

    14. Prescription Medication • Appropriate Use: • Patients with pain / legitimate need • Inappropriate Use: • Abusers / Diverters • No reliable, nationally representative statistics on Rx medication abuse -- NIDA Press Conference

    15. Prescription Drug Diversion • “Doctor Shoppers” • Organized or “sole proprietor” • Abuse, traffic or both • Prescription Fraud • Altered, forged, counterfeit • Theft • Patients, pharmacies • Prescribers • Dated, Duped, Dishonest, Disabled

    16. Prescription Drug Abuse and Diversion Public Health Ramifications: • Experimentation in naïve persons • Mixing multiple drugs and alcohol • Substance abuse • Impacting access for patients with pain

    17. Statutes / Regulation Improved Practice Surveillance / Interventions Risk Management Plans Law Enforcement Access to Addiction Treatment NCE’s & New Formulations Education / Prevention Integrated Approach to Ensuring Proper Use and Curbing Abuse with Opioid Therapy Optimal Public Health

    18. Risk Management Plans:An Evolving Practice • Scheduling • Labeling • Education of Health Care Professionals • Education of Patients and Caregivers • Surveillance Activities • Stepped Interventions • Outcomes Assessment • Re-assessment, Re-emphasis, Revision

    19. Government Encouraging education about pain care and addiction Class labeling Law enforcement Industry Encouraging education about pain care and addiction Risk communication Balancing the Need to Treat Chronic Pain While Limiting Abuse

    20. Anti-Diversion Information

    21. “VOID” appears on photocopied or scanned blanks Tamper-Resistant Prescription Pad

    22. Government Assist with data collection and interpretation on pain, abuse, addiction, diversion Promulgating model State statutes Industry Develop and administer product specific risk management plans Develop progressively abuse resistant formulations Discovery research Balancing the Need to Treat Chronic Pain While Limiting Abuse

    23. The Researched Abuse, Diversion and Addiction-Related Surveillance (RADARS) System™ • Objective: Develop more robust and reliable indicators of diversion or abuse than current publicly accessible databases • Rate estimations on abuse and diversion of specific pharmaceuticals • Earlier signal detection

    24. Health Practitioners Learn about pain care and addiction Support model State statutes Prescribe carefully Academia Educate about pain care and addiction Research best educational practices Research best care practices Balancing the Need to Treat Chronic Pain While Limiting Abuse

    25. Summary - I • There is a significant burden of unnecessary suffering from chronic pain in the US. • Opioids have a significant role in therapy. • Opioids have a recognized abuse potential. • Product specific risk management plans can reduce abuse.

    26. Summary - II • Improvements can and should be made in the assessment and treatment of both pain and substance abuse. • Better data are needed on the prevalence and characteristics of pain, and abuse, addiction, & diversion of Rx medications. • The most cogent approach to protecting patient access to opioids is a multilateral, integrated strategy, based on data.

    27. Conclusion - I • To ensure access to effective and appropriate care for patients with pain, • Curb abuse, • Diagnose and treat addiction, and • Prevent diversion,

    28. Conclusion - II • Regulators, • Health care professionals, • Law enforcement officials, • Industry, • Educators, • Legislators, • The Public, • Must engage in active dialog, respecting differing viewpoints and varying experiences to optimize public health.